827
Participants
Start Date
May 31, 2013
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Formoterol 12 mcg
Formoterol 12 mcg one inhalation twice daily, via dry powder inhaler
Fluticasone propionate 100 mcg
Fluticasone propionate 100 mcg one inhalation twice daily via dry powder inhaler
Fluticasone propionate 250 mcg
Fluticasone propionate 250 mcg one inhalation twice daily via dry powder inhaler
Fluticasone propionate 500 mcg
Fluticasone propionate 500 mcg, one inhalation twice daily via dry powder inhaler
Placebo
Placebo to match formoterol one inhalation twice daily via dry powder inhaler
Novartis Investigative Site, North Massapequa
Novartis Investigative Site, Oaks
Novartis Investigative Site, Gaithersburg
Novartis Investigative Site, Baltimore
Novartis Investigative Site, Winston-Salem
Novartis Investigative Site, Elizabeth City
Novartis Investigative Site, Mt. Pleasant
Novartis Investigative Site, Conyers
Novartis Investigative Site, Stone Mountain
Novartis Investigative Site, Miami
Novartis Investigative Site, Miami
Novartis Investigative Site, Bradenton
Novartis Investigative Site, Memphis
Novartis Investigative Site, Picayune
Novartis Investigative Site, Louisville
Novartis Investigative Site, Louisville
Novartis Investigative Site, Mequon
Novartis Investigative Site, Milwaukee
Novartis Investigative Site, St Louis
Novartis Investigative Site, St Louis
Novartis Investigative Site, Covington
Novartis Investigative Site, Dallas
Novartis Investigative Site, St. George
Novartis Investigative Site, Avondale
Novartis Investigative Site, North Hollywood
Novartis Investigative Site, Cleveland
Novartis Investigative Site, East Greenwich
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY